VERV logo

Verve Therapeutics, Inc. (VERV) EBITDA

annual EBITDA:

-$221.91M-$4.24M(-1.95%)
December 31, 2024

Summary

  • As of today (August 19, 2025), VERV annual EBITDA is -$221.91 million, with the most recent change of -$4.24 million (-1.95%) on December 31, 2024.
  • During the last 3 years, VERV annual EBITDA has fallen by -$136.38 million (-159.44%).

Performance

1-year change

-1.95%

3-year change

-159.44%

5-year change

-1539.38%

15-year change

-1539.38%

VERV EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

-$13.54M

3-year low

-$221.91M
VERV annual EBITDA is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
VERV previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
VERV next annual earnings announcement has not yet been scheduled

OtherVERVincome statement metrics

Annual revenue

$32.33M
VERV annual revenue is $32.33 million

annual net income

-$198.71M
VERV annual net profit is -$198.71 million

annual EBIT

-$228.66M
VERV annual earnings before interest & taxes is -$228.66 million

Annual EPS

-$2.35
VERV annual earnings per share is -$2.35

quarterly EBITDA:

-$34.92M+$19.45M(+35.77%)
March 31, 2025

Summary

  • As of today (August 19, 2025), VERV quarterly EBITDA is -$34.92 million, with the most recent change of +$19.45 million (+35.77%) on March 31, 2025.
  • Over the past year, VERV quarterly EBITDA has increased by +$20.29 million (+36.75%).

Performance

3-month change

+35.77%

1-year change

+36.75%

3-year change

-11.17%

5-year change

-384.73%

VERV quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

-$6.40M

3-year low

-$57.25M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
VERV previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

N/A
VERV next earnings announcement has not yet been scheduled

OtherVERVincome statement metrics

Quarterly revenue

$32.98M
VERV quarterly revenue is $32.98 million

quarterly net income

-$31.03M
VERV quarterly net profit is -$31.03 million

quarterly EBIT

-$36.64M
VERV quarterly earnings before interest & taxes is -$36.64 million

Quarterly EPS

-$0.35
VERV quarterly earnings per share is -$0.35

TTM EBITDA:

-$201.62M+$20.29M(+9.14%)
March 31, 2025

Summary

  • As of today (August 19, 2025), VERV TTM EBITDA is -$201.62 million, with the most recent change of +$20.29 million (+9.14%) on March 31, 2025.
  • Over the past year, VERV TTM EBITDA has increased by +$14.13 million (+6.55%).

Performance

3-month change

+9.14%

1-year change

+6.55%

3-year change

-95.41%

5-year change

-1382.03%

VERV TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

-$7.20M

3-year low

-$221.91M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
VERV previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

N/A
VERV next earnings announcement has not yet been scheduled

OtherVERVincome statement metrics

TTM revenue

$59.61M
VERV TTM revenue is $59.61 million

TTM net income

-$181.01M
VERV TTM net profit is -$181.01 million

TTM EBIT

-$208.45M
VERV TTM earnings before interest & taxes is -$208.45 million

TTM EPS

-$2.11
VERV TTM earnings per share is -$2.11

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$221.91M
VERV annual EBITDA is -$221.91 million

annual net income

-$198.71M
VERV annual net profit is -$198.71 million

annual interest expense

-
VERV annual interest expense value is unknown

annual income tax

$349.00K
VERV annual income tax is $349.00 thousand

annual D&A

$6.75M
VERV annual depreciation & amortization is $6.75 million

VERV EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.9%+36.8%+6.5%
3 y3 years-159.4%-11.2%-95.4%
5 y5 years-1539.4%-384.7%-1382.0%

VERV EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+159.4%at lowat high-39.0%+57.4%-9.1%
5 y5-year+1539.4%at low+445.6%-39.0%+1382.0%-9.1%
alltimeall time+1539.4%at low+445.6%-39.0%+2698.7%-9.1%

VERV EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$34.92M(-35.8%)
-$201.62M(-9.1%)
Dec 2024
-$221.91M(+1.9%)
-$54.37M(-1.4%)
-$221.91M(+0.9%)
Sep 2024
-
-$55.16M(-3.5%)
-$219.97M(+2.0%)
Jun 2024
-
-$57.17M(+3.5%)
-$215.68M(-0.0%)
Mar 2024
-
-$55.21M(+5.3%)
-$215.75M(-0.9%)
Dec 2023
-$217.67M(+33.6%)
-$52.43M(+3.1%)
-$217.67M(+2.7%)
Sep 2023
-
-$50.86M(-11.2%)
-$212.02M(+3.8%)
Jun 2023
-
-$57.25M(+0.2%)
-$204.31M(+8.3%)
Mar 2023
-
-$57.13M(+22.1%)
-$188.60M(+15.8%)
Dec 2022
-$162.88M
-$46.78M(+8.4%)
-$162.88M(+9.9%)
Sep 2022
-
-$43.14M(+3.8%)
-$148.17M(+15.7%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$41.54M(+32.3%)
-$128.11M(+24.2%)
Mar 2022
-
-$31.41M(-2.0%)
-$103.18M(+20.6%)
Dec 2021
-$85.53M(+117.6%)
-$32.07M(+38.9%)
-$85.53M(+20.8%)
Sep 2021
-
-$23.09M(+39.0%)
-$70.81M(+26.3%)
Jun 2021
-
-$16.61M(+20.6%)
-$56.07M(+22.3%)
Mar 2021
-
-$13.77M(-20.6%)
-$45.86M(+16.7%)
Dec 2020
-$39.30M(+190.3%)
-
-
Dec 2020
-
-$17.35M(+107.8%)
-$39.30M(+79.0%)
Sep 2020
-
-$8.35M(+30.4%)
-$21.95M(+61.4%)
Jun 2020
-
-$6.40M(-11.2%)
-$13.60M(+88.8%)
Mar 2020
-
-$7.20M
-$7.20M
Dec 2019
-$13.54M
-
-

FAQ

  • What is Verve Therapeutics, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Verve Therapeutics, Inc.?
  • What is Verve Therapeutics, Inc. annual EBITDA year-on-year change?
  • What is Verve Therapeutics, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Verve Therapeutics, Inc.?
  • What is Verve Therapeutics, Inc. quarterly EBITDA year-on-year change?
  • What is Verve Therapeutics, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Verve Therapeutics, Inc.?
  • What is Verve Therapeutics, Inc. TTM EBITDA year-on-year change?

What is Verve Therapeutics, Inc. annual EBITDA?

The current annual EBITDA of VERV is -$221.91M

What is the all time high annual EBITDA for Verve Therapeutics, Inc.?

Verve Therapeutics, Inc. all-time high annual EBITDA is -$13.54M

What is Verve Therapeutics, Inc. annual EBITDA year-on-year change?

Over the past year, VERV annual EBITDA has changed by -$4.24M (-1.95%)

What is Verve Therapeutics, Inc. quarterly EBITDA?

The current quarterly EBITDA of VERV is -$34.92M

What is the all time high quarterly EBITDA for Verve Therapeutics, Inc.?

Verve Therapeutics, Inc. all-time high quarterly EBITDA is -$6.40M

What is Verve Therapeutics, Inc. quarterly EBITDA year-on-year change?

Over the past year, VERV quarterly EBITDA has changed by +$20.29M (+36.75%)

What is Verve Therapeutics, Inc. TTM EBITDA?

The current TTM EBITDA of VERV is -$201.62M

What is the all time high TTM EBITDA for Verve Therapeutics, Inc.?

Verve Therapeutics, Inc. all-time high TTM EBITDA is -$7.20M

What is Verve Therapeutics, Inc. TTM EBITDA year-on-year change?

Over the past year, VERV TTM EBITDA has changed by +$14.13M (+6.55%)
On this page